Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Somalogic Inc (SLGC)

Somalogic Inc (SLGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 394,951
  • Shares Outstanding, K 188,072
  • Annual Sales, $ 97,670 K
  • Annual Income, $ -109,160 K
  • EBIT $ -154 M
  • EBITDA $ -150 M
  • 60-Month Beta 1.63
  • Price/Sales 4.80
  • Price/Cash Flow N/A
  • Price/Book 0.80
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.69
  • Most Recent Earnings $-0.12 on 11/08/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate -0.13
  • Low Estimate -0.17
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +42.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.93 +8.81%
on 01/05/24
2.77 -24.19%
on 12/06/23
-0.57 (-21.35%)
since 12/05/23
3-Month
1.73 +21.39%
on 10/16/23
2.91 -27.84%
on 12/04/23
-0.16 (-7.08%)
since 10/05/23
52-Week
1.73 +21.39%
on 10/16/23
3.79 -44.59%
on 02/02/23
-0.51 (-19.54%)
since 01/05/23

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHS, SLGC, ORTX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CHS : 7.59 (-0.13%)
SLGC : 2.10 (-4.55%)
ORTX : 16.70 (+0.30%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWLI, MRTX, SLGC, PNT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NWLI : 499.98 (+0.08%)
MRTX : 58.70 (-0.17%)
SLGC : 2.10 (-4.55%)
PNT : 12.50 (+0.16%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SLGC, APRN, FNCB

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SLGC : 2.10 (-4.55%)
APRN : 12.99 (-0.08%)
FNCB : 6.75 (+5.30%)
Why SomaLogic Stock Dived by 10% on Wednesday

The market wasn't impressed by the company's announced tie-up with Standard BioTools.

SLGC : 2.10 (-4.55%)
FLDM : 3.71 (-7.02%)
LAB INVESTOR ALERT: Julie & Holleman LLP Announces Investigation of Proposed Merger Between Standard BioTools and SomaLogic

/PRNewswire/ -- Shareholder rights law firm Julie & Holleman LLP is investigating potential breaches of fiduciary duty relating to the proposed merger between...

LAB : 1.6200 (+0.62%)
SLGC : 2.10 (-4.55%)
Shareholder Alert: Ademi LLP investigates whether SomaLogic, Inc. has obtained a Fair Price in its transaction with Standard BioTools

/PRNewswire/ -- Ademi LLP is investigating SomaLogic (Nasdaq: SLGC) for possible breaches of fiduciary duty and other violations of law in its transaction with...

SLGC : 2.10 (-4.55%)
OncoHost's PROphet® Platform to Support Henlius US-Based Phase III Trial for Patients with Extensive-Stage Small Cell Lung Cancer

/PRNewswire/ -- OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a collaboration...

SLGC : 2.10 (-4.55%)
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too

Cathie Wood is loading up on these healthcare stocks.

BEAM : 23.58 (-3.72%)
ARKG : 23.22 (-0.60%)
RXRX : 5.75 (-4.80%)
SLGC : 2.10 (-4.55%)
Why Shares of SomaLogic Are Up Tuesday

The company showed strong revenue growth in the second quarter.

ILMN : 136.99 (+4.03%)
SLGC : 2.10 (-4.55%)
SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe

/PRNewswire/ -- SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with Dante...

SLGC : 2.10 (-4.55%)

Business Summary

SomaLogic Inc. provides AI-data driven proteomics technology. SomaLogic Inc., formerly known as CM Life Sciences II Inc., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 2.68
2nd Resistance Point 2.49
1st Resistance Point 2.30
Last Price 2.10
1st Support Level 1.92
2nd Support Level 1.73
3rd Support Level 1.54

See More

52-Week High 3.79
Fibonacci 61.8% 3.00
Fibonacci 50% 2.76
Fibonacci 38.2% 2.52
Last Price 2.10
52-Week Low 1.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar